A Selective Barrier Designed to Provide Protection for Acute and Chronic Wounds

Relese is a fenestrated dehydrated complete human placental membrane (dCHPM) allograft. Fenestration of the allograft creates a selective barrier that protects the wound from the surrounding environment while allowing wound exudate to drain. Through the patented Clearify® technology, all three layers of the native placental membrane (amnion, intermediate layer, and chorion) and key structural proteins and components are retained.1

Product Images Website-12

Never delaminated

Easy to handle and apply

4x thicker than the competitor graft1,2

Higher concentration of hyaluronic acid than the competitor allograft1,2

Connect with a StimLabs Representative

Case ReportsCommon Clinical ApplicationsSizes and SKUs

Case Reports

Fenestrated dCHPM Allografts in a Dermatologic Excision Defect

An 86-year-old male with diabetes and a history of numerous NMSCs presented with a large SCC on the distal lateral pretibial region. After excision, the defect measured 5.8 cm x 5.3 cm. A partial reconstruction was performed using a purse-string technique, and fenestrated dCHPM was applied to the remaining defect. After three applications and continued standard wound care, the defect resolved.

RL CR 1 BA-13
RL CR 1 BA-14
Read more

Common Clinical Applications

Wound Types

Acute and chronic wounds such as:

  • Dermatologic Wounds
  • Diabetic Ulcers
  • Pressure Ulcers
  • Surgical Wounds
  • Traumatic Wounds
  • Venous Ulcers

Specialties
Commonly used in specialties such as:

  • Dermatology
  • General Surgery
  • Orthopedic Surgery
  • Plastic Surgery
  • Podiatry
  • Vascular Surgery
Intended Use

Sizes and SKUs

RL Box
Size
2 x 3 cm
4 x 4 cm
6 x 8 cm
SKU RL-2030 RL-4040 RL-6080

Sheet format: Shelf-stable for up to five (5) years

Box symbols

Relese is intended to be used as a selective barrier 1. Data on file. 2. Data is compared to the leading dual-layer allograft and reported as an average. Patents: www.stimlabs.com/patents